...
【24h】

Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.

机译:奥曲肽在婴儿和儿童心脏手术后治疗乳糜胸中的功效。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To examine the efficacy of octreotide in resolving chylothoraces in infants and children following cardiac surgery. DESIGN: Retrospective chart review. SETTING: Pediatric intensive care unit of a tertiary care center. PATIENTS: All children who received octreotide for the treatment of chylothoraces following surgery for congenital heart disease over a 30-month period between 2001-2004. INTERVENTIONS: Octreotide infusion. MEASUREMENTS AND MAIN RESULTS: Eight courses of octreotide treatment were identified in seven patients who met our inclusion criteria. The median duration of therapy was 5 days, and dosing ranged from 1 to 4 microg/kg/hr. Treatment did not result in an overall decrease in average chest tube output after 3 days of therapy. However, in two patients (29%) the chylothoraces ultimately resolved during the octreotide infusion. Treatment was well tolerated, and no serious side effects were noted. CONCLUSION: In contrast to previously published reports, we find octreotide therapy for postoperative chylothoraces to be successful in only a minority of cases.
机译:目的:探讨奥曲肽在心脏手术后解决婴幼儿乳糜中的功效。设计:回顾性图表审查。地点:三级护理中心的儿科重症监护室。患者:2001年至2004年之间的30个月内,因先天性心脏病手术而接受奥曲肽治疗乳糜胸的所有儿童。干预措施:奥曲肽输注。测量和主要结果:在符合我们纳入标准的7例患者中确定了8个疗程的奥曲肽治疗。中位治疗时间为5天,给药剂量为1-4微克/千克/小时。治疗3天后,平均胸总管输出量并未总体下降。然而,在两名患者(29%)中,乳糜泻在奥曲肽输注期间最终消退。治疗耐受性良好,未观察到严重的副作用。结论:与以前发表的报告相反,我们发现奥曲肽治疗乳糜胸的成功仅在少数情况下是成功的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号